Agilent/$A
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Agilent
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
Ticker
$A
Sector
Primary listing
NYSE
Employees
18,100
Headquarters
Website
Agilent Metrics
BasicAdvanced
$38B
29.10
$4.57
1.29
$1.00
0.77%
Price and volume
Market cap
$38B
Beta
1.29
52-week high
$160.27
52-week low
$96.43
Average daily volume
1.8M
Dividend rate
$1.00
Financial strength
Current ratio
1.957
Quick ratio
1.396
Long term debt to equity
45.246
Total debt to equity
49.755
Dividend payout ratio (TTM)
21.64%
Interest coverage (TTM)
13.21%
Profitability
EBITDA (TTM)
1,767
Gross margin (TTM)
52.43%
Net profit margin (TTM)
18.75%
Operating margin (TTM)
21.29%
Effective tax rate (TTM)
9.20%
Revenue per employee (TTM)
$380,000
Management effectiveness
Return on assets (TTM)
8.48%
Return on equity (TTM)
20.62%
Valuation
Price to earnings (TTM)
29.098
Price to revenue (TTM)
5.436
Price to book
5.58
Price to tangible book (TTM)
20.65
Price to free cash flow (TTM)
32.783
Free cash flow yield (TTM)
3.05%
Free cash flow per share (TTM)
4.056
Dividend yield (TTM)
0.75%
Forward dividend yield
0.77%
Growth
Revenue change (TTM)
6.73%
Earnings per share change (TTM)
3.16%
3-year revenue growth (CAGR)
0.48%
10-year revenue growth (CAGR)
5.58%
3-year earnings per share growth (CAGR)
3.02%
10-year earnings per share growth (CAGR)
14.31%
3-year dividend per share growth (CAGR)
5.70%
10-year dividend per share growth (CAGR)
9.51%
What the Analysts think about Agilent
Analyst ratings (Buy, Hold, Sell) for Agilent stock.
Agilent Financial Performance
Revenues and expenses
Agilent Earnings Performance
Company profitability
Agilent News
AllArticlesVideos

Agilent to Announce First-Quarter Fiscal Year 2026 Financial Results on Feb. 25
Business Wire·3 days ago

Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System
Business Wire·2 weeks ago

Agilent to Present at the 44th Annual J.P. Morgan Healthcare Conference
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Agilent stock?
Agilent (A) has a market cap of $38B as of February 05, 2026.
What is the P/E ratio for Agilent stock?
The price to earnings (P/E) ratio for Agilent (A) stock is 29.1 as of February 05, 2026.
Does Agilent stock pay dividends?
Yes, the Agilent (A) stock pays dividends to shareholders. As of February 05, 2026, the dividend rate is $0.999 and the yield is 0.77%. Agilent has a payout ratio of 21.64% on a trailing twelve-month basis.
When is the next Agilent dividend payment date?
The next Agilent (A) dividend payment date is unconfirmed.
What is the beta indicator for Agilent?
Agilent (A) has a beta rating of 1.29. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.